The Vaccine Trials Group is looking for healthy adolescents and young adults aged between 10 and 17 years inclusive, to participate in a study looking at an investigational whooping cough (pertussis) vaccine.
What is whooping cough?
Whooping cough disease is caused by bacteria called Bordetella pertussis. It is a severe respiratory tract infection that kills almost 200,000 children every year worldwide.
The number of infections is increasing around the world, especially in adolescents and adults, and this is thought to be due to waning immunity from the currently recommended pertussis vaccines.
Who can participate?
You may be eligible to participate if you:
Are aged between 10 and 17 years (inclusive)
Are in generally good health
Have received two or more acellular pertussis vaccines in the past
Not had a pertussis-containing vaccine in the last 3 years.
What is expected?
Participants in the study will be required to attend three visits and respond to a follow-up phone call over a 12-week period (home visits may be possible).
Participants will be reimbursed for travel costs incurred.
This study has been approved by the Sydney Children’s Hospitals Network (SCHN) Human Research Ethics Committee (HREC) (approval number: 2020/ETH02847). If you have any concerns or complaints about any aspect of the project or the way it is being conducted, you may contact the Executive Officer of the SCHN HREC on (02) 9845 1253 or SCHNEthics@health.nsw.gov.au.